Skip to main content
Fig. 1 | Virology Journal

Fig. 1

From: HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients

Fig. 1

Mean changes (standard error) in HBsAg (a), HBeAg (b), and HBV DNA (c) levels from baseline according to HBe seroconversion response in HBeAg-positive CHB patients receiving PEG-IFN treatment. *All p-values <0.01 for between-group comparisons at post-baseline time points weeks 12, 24, 48, and 72. p-values <0.01 for within-group comparisons between week 72 and baseline or week 48 for responders who achieved HBe seroconversion

Back to article page

Virology Journal

ISSN: 1743-422X